Thursday, May 26, 2016
Home / Uncategorized




Heading into lunch, this market is not looking lazy.  Price is busy exploring lower in a desperate campaign to reveal buyers.

Early on the NASDAQ put on a  bit of a show by oscillating 30 handles, back-and-forth, in 2 minute increments.  The moves look like EKG bursts as the higher time frame slugged each other in the face, Ali vs Fraser style.

It eventually gave way to more selling.  Although it is true every transaction on the market has one buyer and one seller, right now no one is buying.  Liquidity is low and we are on the verge of another credit crisis.

The market is having one last extreme bipolar fit before the year end–thus assuring itself nothing but coal and a straight jacket for Christmas.


Comments »

Big Surge Triggers Change To Plan


Despite having a bad read on the FOMC reaction I managed to have a decent day. It helps we had a massive rally and my book is without hedge. Naturally I want more.

My largest positions do not put in work like these index moves, they just sort of sit on the sideline fawning the FANG prowess.

More importantly, and much to my chagrin, I missed a big win that Exodus served on a silver platter because the oh shit model had me bearish on Monday. NOTICE: henceforth said model signal will be named the Bunker Buster (h/t Uncle Buccs) and will not be interpreted as bearish. It has always occurred at-or-near lows so it will be considered a BONUS if Exodus already goes oversold.

BOOM: Solutions. We do not wallow in setbacks over here.

Comments »


Film:The Shining (1980) starring JACK NICHOLSON, STANLEY KUBRICK

Bulls had a shot earlier today.  We took out near-term low and quickly responded higher.  But now, as we round the bend and head into the close, biotech is probing back into the lows.

This could accelerate ahead of Friday the 13th.  I am tracking the biotech industry via IBB and trading the comeuppance via BIS.

UPATE: Click the blue date hyperlink below and go take my twitter poll on whether we see a Texas Chainsaw style Massacre tomorrow in biotech:


Comments »

Blame It on The $IBB, Baby


Healthcare is the worst performing sector on the session, currently trading about one and a quarter percent lower. The bulk of the selling is taking place in the home health care industry with hospitals not far behind, but we all know which industry is really to blame here, yes? Investors are being spooked out of those bastard biotech stocks.

The industry, as tracked by IBB, is heading into the close near the low of  the week. Despite shrugging off weakness Monday, it appears the polytetrafluoroethylene (Teflon) surface of this cancerous industry is wearing off.

The industry is swirling with allegations including their hot, 30-year old female Steve Jobs being thrown under the bus AGAIN by The Wall Street Journal.

The hubris level peaked this week, prepare to see all the weak hands flushed down the shitter and back to their home—living with the penguin.

Guess what?  This Friday is the 13th (extra Hitchcock) and the grim reaper will be out for biotech bull blood.

The bloated healthcare sector is leading to the downside here.  Their unicorn, the biotech industry is standing broadside in an open field, and I am perched 30 feet up with a sniper rifle ready to put fifty calibers in its chest.

Comments »

I Made Some Errors Today


I woke up rested, had a proper breakfast, saw to my morning preparations, lit my ritualistic death to biotech candle, but still managed to make some errors during the session.

Sometimes you do everything right but still make mistakes—for now I am still human. A few things tripped me up:

  • Gaps into a new week often get faded
  • TRIN had abnormal readings which call the first move of the day into question.

The problem with the above two events is they have no data behind them. I never ran a study to quantify the validity of these observations. Slippery footing gives way fast when you get out of sync with the market flow.

As a result, despite coming into the week with a short bias, I was trying to fade the market by 11am. Try is the key word because it felt forced. I managed to escape break even the first time but the second fade try took a drop dead stop—something I have not done in over a month.

Meanwhile, biotech was bulletproof. The industry even shrugged off another Citron attack. I am still short via BIS, but I feel like I am standing blindfolded in front of a firing squad.

When the market gives me a good spine twist I like to make sure my mental game is still centered. I am off to find my inner voice and listen to it until it stops talking o_0

I am also looking forward to hearing The Option Addict run through the investor conference content again.  Expert commentary is always useful when assessing your own strategy and approach.

Comments »

Alibaba Acquires Youku


Merger news out of  China this morning as Alibaba acquires Youku Toudu for $27.60/share.

Youku Toudu is China’s version of You Tube.  You see the resemblance, yes?  This deal united two of their big internet components, but who are we kidding?  It is all owned by the governement.

YOKU shares up trading just below $27/share as we head into Nonfarm payroll.

Comments »

Still Looks Creepy


Until the conditions can improve underneath the surface of index prices, the model is going to keep generating a short bias.

This is the fourth consecutive week where the bias model is calling for the short. Unbelievable, that’s pretty much the entire month of October. The NASDAQ composite is up 6.88% over the period, it’s best run of the year, and the model is flat out on the wrong side of the tape.

It makes me have a few thoughts—the first is that we are undergoing a shift in the marketplace which is causing my spread to stay pinned to the high side. The second thought is only a few stocks are doing the lifting which is pressuring the hybrid score.

Nevertheless, I would be remiss to ignore the bias. I will be working the short side of the tape this week. I may even initiate BIS again as I eagerly await the ultimate biotech comeuppance—an event so horrific and gruesome that minces biotech investors into little cubes of meat to be served on skewers.

Thanks again to everyone who made it out to NYC this weekend.  I had a blast catching up with you guys–especially the trading conversations.  A sincere hat tip to you.


Comments »

Initial Observations of Fall in NYC


This is my first time in the city during the fall.  Back home this is my favorite time of year, a seasonal crescendo featuring harvests and natural colors.  Here in the city it means a cool clime and hopefully lots of mysterious looking goons and goblins.

I already witnessed a women on the subway with demonic eyeballs.  Hopefully an effect achieved through theatric contact lense, but how can I be sure?  Night comes earlier here not only because of the towering cityscape but also because it’s a few 100 miles deeper into the eastern time zone.  Hopefully its arrival brings forth the real freaks.

It certainly smells better today then the thick summer air.

Overall the mood is positive.  I made it to the (undisclosed location) from the Laguardia flea marketfor about $3 via bus and rail.  I’m excited to see the crew and all the conference attendees tomorrow.  But tonight I see the city.  Shoot me at DM @imdexmodel if you’ll be around the East Villiage tonight.  Something tells me I’ll end up there.

As for the markets: had I not held on to on some high risk weekly LNKD calls while flying east The market would have blown my head off because both LULU and FEYE were DECIMATED.  What a cruel rally.

These are battles I will resume next week after Option Addict and the finance triumvirate meet in the war room and hash out a  year end plan.

Comments »



The artist formerly known as Google just reported an earnings beat, and Amazon is making profit–effectively disintegration short sellers into piles of soot.

The tech rally was saved today when Facebook negated the failed auction.  This permitted best-in-breed tech to be pressed with reckless abandon.

This is the great NASDAQ rally the tea leaves inside Exodus foretold.  Another devastating win for the software.

Look for more NASDAQS tomorrow.  Tech is officially on FIRE.

Comments »

Let’s Hope Nowak Is Wrong About Twitter


My book is undergoing a blitzkrieg this morning after my largest investment, Twitter, was downgraded by Morgan Stanley. Issuing the decree was a man by the name of Brian Nowak who sees fit to single handedly take on Steve Ballmer and Prince Alwaleed in the high stakes game of valuing a social media company.

Nowak spouted off big words about mobile advertising. He obfuscated the matter with acronyms. He sounded, for all intents and purposes, really fancy and better than us.

With Twitter scheduled to report earnings October 27th it won’t be long until we can see if he is right.

Twitter has been a problem child all year. There were management issues, for a while they had no CEO, and the platform is criticized for being too esoteric for the common plebeian to use. I know, eventually, it will see adoption, but then again I am optimist who thinks highly of his fellow citizen.

I am still watching Facebook today. If that stock starts moving fast to the downside my concern levels will elevate rather quickly. In the meantime I got back into BISe early on for the #TeamHillary trade.

Final note, I think Brian is the most reprehensible name in the English catalog.  It looks like brain and I’d like to punch it with my fist like a cave man.

Comments »